1385 Divergent therapeutic outcomes of STING agonist ADU-S100 in intratumoral and intravesical treatment regimens in syngeneic murine MB49 and in the N-methyl-N-nitrosourea (MNU) rat model of urothelial carcinoma
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.